Antibacterial resistance induced by recombinant interleukin 1 in myelosuppressed mice: Effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 128 (1) , 250-260
- https://doi.org/10.1016/0008-8749(90)90023-k
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytesPublished by Elsevier ,2004
- An assay for growth of mouse bone marrow cells in microtiter liquid culture using the tetrazolium salt MTT, and its application to studies of myelopoiesisImmunology Letters, 1988
- Recombinant human interleukin 1α enhances anti-Listeria resistance in both genetically resistant and susceptible strains of miceImmunology Letters, 1988
- Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 betaInflammation Research, 1988
- A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.The Journal of Experimental Medicine, 1988
- Enhanced Hematopoietic Recovery in Irradiated Mice Pretreated with Interleukin-1 (IL-1)Immunopharmacology and Immunotoxicology, 1987
- Neutrophil Emigration and Microvascular InjuryPathology and Immunopathology Research, 1987
- In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse.Journal of Clinical Investigation, 1986
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Differing Contribution of Polymorphonuclear Cells and Macrophages to Protection of Mice against Listeria monocytogenes and Pseudomonas aeruginosaJournal of General Microbiology, 1979